A new report reveals that the U.S. adult obesity rate has declined to 37% in 2025, down from a record 39.9% in 2022, as more Americans turn to weight loss drugs like GLP-1 injectables. With 7.6 million fewer obese adults, is this the start of a healthier trend?
A recent Gallup survey reveals a rapid increase in the use of injectable obesity treatments, correlating with a drop in obesity rates among U.S. adults. Discover the implications and future of these groundbreaking medications!
Are you one of the many Americans using GLP-1 drugs like Ozempic or Wegovy? Discover essential lifestyle tips to prevent nutrient deficiencies and muscle loss while maximizing your weight loss results!
A groundbreaking trial reveals that Mounjaro is more effective than Wegovy for weight loss, achieving a 20% reduction over 72 weeks compared to Wegovy's 14%. Discover the implications for obesity treatment!
